Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Nkarta (NKTX)
NASDAQ:NKTX
Nkarta (NKTX) Stock Price & Analysis
158 Followers
NKTX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.12 - $18.48
Previous Close$4.55
Volume148.57K
Average Volume (3M)401.44K
Market Cap
$222.65M
Enterprise Value-$9.39M
Total Cash (Recent Filing)$323.34M
Total Debt (Recent Filing)$91.29M
Price to Earnings (P/E)-1.8
Beta0.88
Next Earnings
Aug 10, 2023EPS Estimate
-$0.65Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.49
Shares Outstanding48,934,928
10 Day Avg. Volume275,692
30 Day Avg. Volume401,441
Standard Deviation0.28
R-Squared0.00098
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)0.64
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-2.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.07
Forecast
1Y Price Target
$24.67Price Target Upside442.20% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Nkarta News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NKTX FAQ
What was Nkarta’s price range in the past 12 months?
Nkarta lowest stock price was $3.12 and its highest was $18.48 in the past 12 months.
What is Nkarta’s market cap?
Currently, no data Available
When is Nkarta’s upcoming earnings report date?
Nkarta’s upcoming earnings report date is Aug 10, 2023 which is in 75 days.
How were Nkarta’s earnings last quarter?
Nkarta released its earnings results on May 11, 2023. The company reported -$0.63 earnings per share for the quarter, beating the consensus estimate of -$0.674 by $0.044.
Is Nkarta overvalued?
According to Wall Street analysts Nkarta’s price is currently Undervalued.
Does Nkarta pay dividends?
Nkarta does not currently pay dividends.
What is Nkarta’s EPS estimate?
Nkarta’s EPS estimate is -$0.65.
How many shares outstanding does Nkarta have?
Nkarta has 48,934,930 shares outstanding.
What happened to Nkarta’s price movement after its last earnings report?
Nkarta reported an EPS of -$0.63 in its last earnings report, beating expectations of -$0.674. Following the earnings report the stock price went up 0.447%.
Which hedge fund is a major shareholder of Nkarta?
Among the largest hedge funds holding Nkarta’s share is RA Capital Management. It holds Nkarta’s shares valued at 28M.
---
Nkarta Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$24.67 (442.20% Upside)
$24.67 (442.20% Upside)
Blogger Sentiment
Bullish
NKTX Sentiment 100%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Negative
Last 7 Days ▼ 0.6%
Last 30 Days ▼ 1.4%
Last 30 Days ▼ 1.4%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-63.51%
12-Months-Change
Fundamentals
Return on Equity
-41.25%
Trailing 12-Months
Asset Growth
49.58%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Nkarta
Nkarta Inc is a bio-pharmaceutical company focused on the discovery, development and commercialization of engineered, allogeneic, and off-the-shelf cell therapies to treat cancer.
---
Top 5 ETFs holding NKTX
iShares NASDAQ US Biotechnology UCITS ETF
$104.07K
Invesco Nasdaq Biotechnology ETF
$4.14K
Up to five ETFs with an Outperform Smart Score that hold NKTX. The ETFs are listed according to market value of NKTX within the ETF
---
Karyopharm Therapeutics
―
Monte Rosa Therapeutics
―
Biohaven Ltd.
―
Atara Biotherapeutics
―
Aura Biosciences Inc
―
---